$CVS

CVSCVS Health Corporation Common Stock

YouTube 频道最近怎么谈 CVS Health(CVS)?

过去 30 天(截至 11-18),4 个 YouTube 频道谈到 CVS Health(CVS),共 4 条。最近一条:Parkev Tatevosian, CFA,2026-11-04。

本窗口内的全部观点与内容

截至 11-18
11-04
Parkev Tatevosian, CFA发布 2026-11-04
《Huge News for CVS Stock Investors》
$CVS看涨
AI 摘要 · 据报道,CVS 计划分拆其零售药房业务,该业务面临门店客流减少和工资上涨的压力;说话者认为这是积极进展,使其对 CVS 的长期前景更为乐观,并以较低的信心和把握重申买入评级。CVS 股价为 91.41 美元,低于其超过 120 美元的公允价值估计;其 10.72 倍的远期市盈率低于华尔街约 12% 的每股收益增长预期,但超过 740 亿美元的长期债务是主要担忧。

CVS 股票的投资者迎来了重大消息:据彭博社报道,该公司正在讨论剥离其零售药房业务的计划。这可能是一项规模巨大的工程,因为无论从过去十二个月的营收还是现有门店数量来看,CVS Health 都是全球最大的公司之一。

We have huge news for CVS stock investors, as Bloomberg reports that the company is discussing plans to spin off its retail pharmacy business. This could be a huge undertaking, given that CVS Health is one of the largest companies in the world, both in terms of its revenue over the past twelve months and the number of its existing locations.

他说在等
下一次季度投资者更新中关于零售药房业务剥离的细节
管理层确认并详细说明分拆流程
下一次季度更新下一次季度投资者更新
支持买入逻辑
The Motley Fool发布 2026-11-04
《AMD's Earnings & Why Stocks Are Surging Today》
$CVS中性
AI 摘要 · CVS 在2028年初前拆分为零售药房与 CVS Health 部门(PBM、Aetna、诊所),此举合理,且可能释放被压制的价值;但两家独立公司都不是说话者会买入的:零售业务面临与 Amazon 的长期竞争,保险业务则面临利用率飙升和报销方式变化。CVS Health 是更耐人寻味的一块;其中一部分可能成为收购目标,不过这一点仍有待观察。

我们今天要聊 AMD,还有 CVS 的分拆,但我们必须先从今天的新闻说起。

We're going to talk today about AMD and also a split at CVS, but we have to start with the news of the day.

我们回来后,会聊到 CVS 从整合者转向去整合。几十年来,CVS 似乎一直处于整合阶段,不断增设更多门店。后来他们进入了保险业务,但这对投资者来说并没有特别奏效。过去十年,该股仅上涨了5%。

When we come back, we're going to get to CVS going from consolidator to deconolidating. For decades, it seems like CVS has been in consolidation phase, adding more and more stores.

Then they got into the insurance business, but that hasn't worked particularly well for investors. The stock's up just 5% in the past decade.

Schwab Network发布 2026-11-04
《CVS Dismantling Healthcare Empire: Regulatory Tailwinds v. Cost Headwinds》
$CVS中性
AI 摘要 · CVS的分拆(不早于2028年)并不能证明其整合战略失败:零售药房已提升份额并恢复健康增长,此举是对PBM透明度要求和田纳西州所有权规则的回应。但12%的跌幅反映的是分部加总估值逻辑——零售同行估值为7至8倍EBITDA,而保险公司为11.5至12.5倍——以及新增的双重上市成本;独立估值是关键。除非国会采取行动,垂直整合很可能继续。

CVS花了多年时间打造出这个综合医疗保健巨头,结果现在在战略评估中却说:“我们要拆分成两家上市公司。”这是否等于承认它没有像他们期望的那样成功,管理层也没有实现外界对它的预期?

I mean, CVS spent years building this integrated healthcare giant , only to come along now as part of its strategic evaluation and say, "We're going to split into two publicly traded companies ."

Is this an admission that it did not succeed as they wanted, and that the administration did not achieve what was expected of it ?

他说在等
国会采取实际的政府行动来拆分这些实体
国会采取实际行动拆分这些实体
未来几年国会
削弱垂直整合将持续下去的观点
Meet Kevin发布 2026-11-04
《The Stock Market & Morning After Election 2026.》
$CVS看涨
AI 摘要 · CVS长期以来是说话者的最爱之一,原因是其药房业务部门的扭亏为盈以及拆分为两家上市公司;第三季度营收为1084亿,并上调了全年盈利指引。股价可能尚未反映这一点,但股市在大变化上常常出错;视频还指出,尽管面对沃尔玛和亚马逊,CVS仍实现了两年的市场份额增长,这归功于经营实力。

CBS Health 一直是我最看好的之一,因为药店业务出现了转机,它正在拆分成两家上市公司。它公布第三季度营收 1084 亿,并上调了全年盈利展望。从股价上看不出来,但面对重大变化时,股价往往是错的。

CBS Health, long one of my favorites because of the turn that has happened in the in the drugstore division, uh, is splitting into two public companies. This reports third quarter revenue of 108.4 billion, raises its fullear earnings outlook.

You can't tell from the stock, but stocks are often wrong when it [music] comes to what big changes.

已显示 4 / 本页 4 条
看这只股票的全部记录